Effects of Pulsed Electromagnetic Fields (PEMFS) On Cerebral Haemodynamics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-22

Study Completion Date

2021-02-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are looking to determine the effects of PEMFs device on cerebral blood flow and cognition in healthy volunteers. Through in vitro tests and in vivo animal studies, the investigators have shown that at an extremely low flux density (strength) of 1 millitesla (mT) and with short exposures of 10 minutes a week, PEMFs can recapitulate many of the healthful benefits of exercise without imparting a mechanical stress on the tissues and cells.

In the first-in-man study, 10 healthy volunteers were exposed to PEMFs for 6 weeks with 10 minutes of field exposure per week, and experienced an average increase of 30% in leg strength. No side effects were reported.

In this study, the investigators aim to understand the cerebral effects of an exercise mimetic (PEMFs) via the muscle milieu.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization

NCT06744764

Haematological Cancer Healthy

RECRUITING NA

Pulsed Electromagnetic Field (PEMF) Systems to Promote the Maintenance of Bone and Muscle

NCT03165318

Muscle Loss Post Anterior Cruciate Ligament Reconstruction

UNKNOWN NA

Effect of Electromagnetic Field Therapy on Balance and Gait in Paraparetic Patients

NCT07196956

Paraparesis Gait Disorders, Neurologic Postural Balance Disorders

NOT_YET_RECRUITING NA

PEMF Stimulation on Physical Exercise in Sedentary People

NCT06446466

PEMF Effect

COMPLETED NA

Pilot Study On Pulsed Electromagnetic Field Therapy For Osteosarcopenia

NCT05043480

Sarcopenia Osteopenia or Osteoporosis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Human and animal studies have reported the beneficial influence of exercise on cognitive and brain functions. Accordingly, exercise is drawing increasing research attention as a possible lifestyle factor for improving neurocognitive functions.

Low frequency and low amplitude Pulsed Electromagnetic Fields (PEMFs) recapitulate many of the benefits of exercise by activating many of the same cellular second messenger cascades activated by mechanical input (exercise) yet, without imparting a physical stress on the cells. Through a series of in vitro and in vivo experiments the investigators have shown that at field strengths of 1-2 mT amplitude, the PEMF system stimulates muscle without physically stressing the tissues and delivers the following benefits: 1) slows muscle loss, 2) improves muscle strength and, 3) releases important regenerative and metabolism-enhancing agents.

Functional near-infrared spectroscopy (fNIRS) is a relatively new optical imaging technology that uses light in the near-infrared spectrum to non-invasively monitor the haemodynamic responses evoked by neural activity through measuring the changes in oxyhaemoglobin (HbO) and deoxyhaemoglobin (HbR) concentrations in the cerebral cortex. The increased blood supply to the area of neural activation typically results in an increase in HbO concentration while a decrease is observed in HbR due to the blood's washout effect. The HbO and HbR responses from fNIRS measurements have been shown to be spatially and temporally correlated with the blood oxygen level-dependent signal obtained by fMRI. The advantage of fNIRS over other imaging modalities is that it is inexpensive, non-invasive, non-ionising and portable, making it a highly popular modality for implementing brain-computer interfaces. OBELAB NIRSIT is a commercially available, high-density fNIRS device that optically measures haemodynamic variations in the pre-frontal cortex (PFC).

Low-frequency and low amplitude pulsed electromagnetic fields (PEMFs) recapitulate many of the healthful benefits of exercise by activating many of the same cellular second messenger cascades activated by mechanical input (exercise) yet, without imparting a physical stress on the cells. Response windows are a largely unrecognised rule in mechanobiological systems, whereby cells are most responsive to a given strain, duration and frequency of stimulation; greater strain of higher frequency and duration of stimulation is too much of a stress for cells and results in null responses.

The investigators have shown that PEMFs likewise obey an electromagnetic window of efficacy with temporal and frequency dependencies of similar scale as those required for mechanical stimulation, further supporting the conclusion that PEMFs are activating cellular mechanotransduction pathways. At field strengths of 1-2 mT amplitude, the PEMF system stimulates muscle without physically stressing the tissues and aims to deliver the following benefits: 1) slows muscle loss; 2) improves muscle strength and; 3) releases important regenerative and metabolism-enhancing agents. Accordingly, this study will investigate the exercise mimetic effects of PEMFs on cerebral haemodynamics and cognitive performance via targeting muscle. The results of this study will support future work with patients with memory deficits, such as mild cognitive impairment, to possibly mitigate disease progression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Hemodynamics Cognitive Change

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study is designed as a double-blinded, randomised, controlled pilot study. As a pilot study, 33 healthy adults will be enrolled and randomised into the intervention or sham arm at 2:1 ratio. Within the intervention arm, 50% of the participants will receive PEMFs in the non-dominant leg and the remaining 50% will receive intervention in the dominant leg (n = 11, 11). There are no restrictions based on race or gender.

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulsed Electromagnetic Field Therapy (Dominant leg)

Active Pulsed Electromagnetic Field therapy; exposed once weekly for 10 minutes on dominant leg.

Group Type EXPERIMENTAL

Pulsed Electromagnetic Fields Therapy (Dominant leg)

Intervention Type DEVICE

Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Fields on their dominant leg once a week for a total of 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

The PEMF device produces pulsed magnetic fields at flux densities up to 1.5 mT peak.

Pulsed Electromagnetic Field Therapy (Non-dominant leg)

Active Pulsed Electromagnetic Field therapy; exposed once weekly for 10 minutes on non-dominant leg.

Group Type EXPERIMENTAL

Pulsed Electromagnetic Fields Therapy (Non-dominant leg)

Intervention Type DEVICE

Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Fields on their non-dominant leg once a week for a total of 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

The PEMF device produces pulsed magnetic fields at flux densities up to 1.5 mT peak.

Sham Therapy (Control)

Inactive Pulsed Electromagnetic Field therapy; exposed once weekly for 10 minutes.

Group Type SHAM_COMPARATOR

Sham Therapy (Control)

Intervention Type DEVICE

Participants of this arm will be not be exposed to the fields. Sham treatment will utilise the same PEMF apparatus for 10 minutes, but in non-operational mode, which is indistinguishable from when the apparatus is in operation. Duration of intervention is 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulsed Electromagnetic Fields Therapy (Dominant leg)

Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Fields on their dominant leg once a week for a total of 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

The PEMF device produces pulsed magnetic fields at flux densities up to 1.5 mT peak.

Intervention Type DEVICE

Pulsed Electromagnetic Fields Therapy (Non-dominant leg)

Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Fields on their non-dominant leg once a week for a total of 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

The PEMF device produces pulsed magnetic fields at flux densities up to 1.5 mT peak.

Intervention Type DEVICE

Sham Therapy (Control)

Participants of this arm will be not be exposed to the fields. Sham treatment will utilise the same PEMF apparatus for 10 minutes, but in non-operational mode, which is indistinguishable from when the apparatus is in operation. Duration of intervention is 6 weeks. A minimum of 5-day and maximum of 9-day interval between each treatment session shall be followed.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PEMF MRegen PEMF MRegen

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 21- 65 years
* Ability to provide informed consent

Exclusion Criteria

* Received any investigational drug or device within 30 days prior to study baseline visit or is enrolled in another clinical trial
* History of cardiac, neurological, or rheumatic diseases
* History of malignancy within the past 5 years
* Undergone surgery of any type within the past 6 months
* Anticipated need for surgery of any type during the next 3 months
* Previous treatment with the study device
* Metal implants in the lower limb
* Existing or planned pregnancy
* Lactating women
* Leg circumference \> 63 cm
* Colour vision deficiency

Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes